BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38094210)

  • 1. Successful Treatment of Recurrent Pericarditis With Rilonacept in Acute Promyelocytic Leukemia.
    Atar M; Majid M; Yaker Z; Agrawal A; Arockiam AD; Gerds AT; Kafil T; Shimshak T; Brands C; Klein AL
    JACC Case Rep; 2023 Nov; 25():102043. PubMed ID: 38094210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
    Dang CC; Guan YK; Lau NS; Chan SY
    J Oncol Pharm Pract; 2020 Dec; 26(8):2034-2037. PubMed ID: 32279594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
    Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
    Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe Wernicke encephalopathy and acute pancreatitis due to all-trans-retinoic acid and arsenic trioxide during treatment of acute promyelocytic leukaemia: a case report.
    Jiang Y; Ji L
    J Int Med Res; 2020 Sep; 48(9):300060520959487. PubMed ID: 32993392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.
    Zhang Y; Wu S; Luo D; Zhou J; Li D
    PLoS One; 2016; 11(1):e0147545. PubMed ID: 26812490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia.
    Che-Pin Lin ; Huang MJ; Chang IY; Lin WY; Sheu YT
    Leuk Lymphoma; 2000 Jun; 38(1-2):195-8. PubMed ID: 10811463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.
    Zhu HH; Wu DP; Du X; Zhang X; Liu L; Ma J; Shao ZH; Ren HY; Hu JD; Xu KL; Wang JW; Song YP; Fang MY; Li J; Yan XY; Huang XJ
    Lancet Oncol; 2018 Jul; 19(7):871-879. PubMed ID: 29884593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocotrienols-enriched Self-nanoemulsifying Drug Delivery System Enhances the Antileukemic Activity of All-trans Retinoic Acid but not Electrocardiogram Alterations Evoked by Its Combination with Arsenic Trioxide.
    Borges GSM; Sicard P; de Mello Gomides Loures C; Evangelista FGC; Sales CC; de Paula Sabino A; Fernandes C; Ferreira LAM; Richard S
    AAPS PharmSciTech; 2023 Mar; 24(3):79. PubMed ID: 36918482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of combination therapy with all-trans retinoic acid and arsenic trioxide on acute promyelocytic leukemia].
    Zhang GC; Zheng D; Li QH; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
    Ai Zheng; 2004 Apr; 23(4):430-4. PubMed ID: 15087033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral arsenic trioxide incorporation into frontline treatment with all-trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5-year prospective study.
    Gill H; Kumana CR; Yim R; Hwang YY; Chan TSY; Yip SF; Lee HKK; Mak V; Lau JSM; Chan CC; Kho B; Wong RSM; Li W; Lin SY; Lau CK; Ip HW; Leung RYY; Lam CCK; Kwong YL
    Cancer; 2019 Sep; 125(17):3001-3012. PubMed ID: 31090936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and the Adverse Effects of Oral Versus Intravenous Arsenic for Acute Promyelocytic Leukemia: A Meta-Analysis of Randomized-Controlled Studies.
    Sasijareonrat N; Jahn N; Ungprasert P; Owattanapanich W
    Technol Cancer Res Treat; 2020; 19():1533033820937008. PubMed ID: 32583728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Treatment With ATRA and Arsenic Trioxide for a Child With Down Syndrome and Acute Promyelocytic Leukemia.
    Tsumura Y; Yamada Y; Osumi T; Kato M; Terashima K; Shioda Y; Kiyotani C; Matsumoto K; Tomizawa D
    J Pediatr Hematol Oncol; 2020 May; 42(4):322-325. PubMed ID: 30807394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [All-trans retinoic acid/arsenic trioxide combination therapy for a patient with acute promyelocytic leukemia on dialysis].
    Nagao R; Hosoba R; Yahagi Y; Gunji T; Uryu H; Hattori D; Momoki M; Yamazaki H
    Rinsho Ketsueki; 2019; 60(10):1431-1435. PubMed ID: 31695003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of combination of all-trans retinoic acid and arsenic trioxide on apoptosis of acute promyelocytic leukemia cells.
    Hu J; Sun Q; Fang W; Wang Q
    Cell Mol Biol (Noisy-le-grand); 2019 Apr; 65(4):97-100. PubMed ID: 31078158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How retinoic acid and arsenic transformed acute promyelocytic leukemia therapy.
    Korsos V; Miller WH
    J Mol Endocrinol; 2022 Nov; 69(4):T69-T83. PubMed ID: 36112505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation syndrome-induced Myopericarditis in the induction therapy of acute Promyelocytic leukemia: a case report.
    Shenoy SM; Di Vitantonio T; Plitt A; Perez-Johnston R; Gutierrez J; Knorr DA; Stein EM; Liu JE; Feldman S
    Cardiooncology; 2021 Nov; 7(1):39. PubMed ID: 34814948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term retrospective study of retinoic acid combined with arsenic and chemotherapy for acute promyelocytic leukemia.
    Zhang X; Wu S; Yang J; Zhang G; Su Y; Zhang M; He J; Shi Y; Li W; Lu P; Lu D
    Int J Hematol; 2023 Apr; 117(4):530-537. PubMed ID: 36580227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Rare Case of Acute Pericarditis as a Primary Presentation of Differentiation Syndrome.
    Alyami B; Alharbi AA; Patel B
    Cureus; 2022 Apr; 14(4):e24213. PubMed ID: 35463565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Brief Overview of Recurrent Pericarditis Management and the Potential of Rilonacept as a New Therapeutic Option.
    Gupta M; Kaul S; Velazquez GR; Bandyopadhyay D; Fonarow GC; Klein A; Ghosh RK
    Am J Cardiovasc Drugs; 2022 Jan; 22(1):27-33. PubMed ID: 34008144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of relapsed acute promyelocytic leukemia with arsenic trioxide in a hemodialysis-dependent patient: A case report.
    Lee HJ; Park SG
    World J Clin Cases; 2020 Nov; 8(21):5347-5352. PubMed ID: 33269269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.